Showing results (2141-2150 of 2,251) with videos related to
Sort By:
Pageof 226
Ophthalmology and Therapy|February 3, 2026
One-Year Real-World Outcomes of Aflibercept 8 mg in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network ReportGabriela Grimaldi, Nicolò Bartolomeo, Justus G Garweg, et al.Molecular Autism|October 4, 2023
The neuroanatomical substrates of autism and ADHD and their link to putative genomic underpinningsLisa M Berg, Caroline Gurr, Johanna Leyhausen, et al.Clinical Chemistry|August 6, 2005
High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signaturesMary F Lopez, Alvydas Mikulskis, Scott Kuzdzal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimization and selectivity studyJorge E Cortes, Michele Baccarani, François Guilhot, et al.Ophthalmology and Therapy|October 17, 2025
One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network ReportAnne Tillmann, Richard Stillenmunkes, Justus G Garweg, et al.Optics Express|February 1, 2024
Development towards high-resolution kHz-speed rotation-free volumetric imagingEleni Myrto Asimakopoulou, Valerio Bellucci, Sarlota Birnsteinova, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 15, 2025
Access to pediatric trauma centres in Canada: a population-based retrospective cohort studyAlexandra Lapierre, Carmel Awlise, Gabrielle Freire, et al.Cell Reports|May 3, 2019
Anaerobic Glycolysis Maintains the Glomerular Filtration Barrier Independent of Mitochondrial Metabolism and DynamicsPaul T Brinkkoetter, Tillmann Bork, Sarah Salou, et al.The New England Journal of Medicine|April 12, 2014
Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirinStefan Zeuzem, Ira M Jacobson, Tolga Baykal, et al.Journal of the American Society of Nephrology : JASN|March 9, 2017
Targeting mTOR Signaling Can Prevent the Progression of FSGSStefan Zschiedrich, Tillmann Bork, Wei Liang, et al.Pageof 226